X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-06-02 | RPID | Kennedy Lewis Management LP | 10% | P - Purchase | $4.72 | +60,100 | 2,904,490 | +2% | +$283,597 | |||||
| M | 2022-05-27 | RPID | Kennedy Lewis Management LP | 10% | P - Purchase | $4.87 | +68,617 | 2,869,154 | +2% | +$334,441 | |||||
| M | 2022-05-25 | RPID | Kennedy Lewis Management LP | 10% | P - Purchase | $4.59 | +49,883 | 2,828,810 | +2% | +$228,874 | |||||
| M | 2022-05-17 | RPID | Kennedy Lewis Management LP | 10% | P - Purchase | $4.08 | +96,516 | 2,799,481 | +4% | +$393,795 | |||||
2022-05-16 | RPID | Spignesi Robert G. Jr. | Pres, CEO | P - Purchase | $3.80 | +10,000 | 194,027 | +5% | +$37,950 | ||||||
2022-03-10 | RPID | Lowenstein Inese | Dir | P - Purchase | $6.95 | +10,000 | 10,000 | New | +$69,500 | ||||||
| D | 2021-07-19 | RPID | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $20.00 | +100,000 | 8,434,560 | +1% | +$2,000,000 | |||||
| D | 2021-07-19 | RPID | Longitude Capital Partners Ii, LLC | 10% | P - Purchase | $20.00 | +150,000 | 3,557,952 | +4% | +$3,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |